387511003: Cytarabine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Antimetabolite (substance)\Pyrimidine analog (substance)\Cytarabine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunologic agent (substance)\Pyrimidine analog (substance)\Cytarabine (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Antimetabolite (substance)\Pyrimidine analog (substance)\Cytarabine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine analog (substance)\Cytarabine (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine analog (substance)\Cytarabine (substance)
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine analog (substance)\Cytarabine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cytarabine (substance)	Is a	Pyrimidine	false	Inferred relationship	Some
Cytarabine (substance)	Is a	Pyrimidine analog (substance)	true	Inferred relationship	Some
Cytarabine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that competes with, replaces or inhibits a specific metabolite of a cell and thereby interferes with the cell's normal metabolic functioning.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Poisoning by cytarabine	Causative agent	True	Cytarabine (substance)	Inferred relationship	Some	1
Accidental cytarabine poisoning	Causative agent	False	Cytarabine (substance)	Inferred relationship	Some
Intentional cytarabine poisoning	Causative agent	False	Cytarabine (substance)	Inferred relationship	Some
forgiftning med cytarabin, uvist med hvilken hensigt	Causative agent	False	Cytarabine (substance)	Inferred relationship	Some	1
Cytarabine adverse reaction	Causative agent	True	Cytarabine (substance)	Inferred relationship	Some	1
Allergy to cytarabine	Causative agent	False	Cytarabine (substance)	Inferred relationship	Some
Cytarabine overdose	Causative agent	True	Cytarabine (substance)	Inferred relationship	Some	1
Accidental cytarabine overdose	Causative agent	True	Cytarabine (substance)	Inferred relationship	Some	1
Intentional cytarabine overdose (disorder)	Causative agent	True	Cytarabine (substance)	Inferred relationship	Some	1
overdosis af cytarabin, uvist med hvilken hensigt	Causative agent	False	Cytarabine (substance)	Inferred relationship	Some	1
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 20 mg/ml injektionsvæske, opløsning, hætteglas a 25 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 1 g pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 20 mg/ml injektionsvæske, opløsning 5ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 100 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 100 mg pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
Cytarabine 500mg/vial injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
Cytarabine 1g/vial injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
Cytarabine 2g/vial injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
Cytarabine 10mg/mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
liposomalt cytarabin 50 mg/5 ml injektionsvæske, hætteglas a 5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
Product containing cytarabine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cytarabine (substance)	Inferred relationship	Some	1
cytarabin 500 mg pulver til injektionsvæske, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 1 g/pulver til injektionsvæske, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
cytarabin 2 g/pulver til injektionsvæske, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cytarabine (substance)	Inferred relationship	Some
Cytarabine liposome	Is a	False	Cytarabine (substance)	Inferred relationship	Some
Accidental cytarabine poisoning	Causative agent	True	Cytarabine (substance)	Inferred relationship	Some	1
Intentional cytarabine poisoning	Causative agent	True	Cytarabine (substance)	Inferred relationship	Some	1
Allergy to cytarabine	Causative agent	True	Cytarabine (substance)	Inferred relationship	Some	1
Cytarabine-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cytarabine (substance)	Inferred relationship	Some	1
Cytarabine liposome	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Cytarabine (substance)	Inferred relationship	Some
Product containing precisely cytarabine 1 gram/10 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 1 gram/10 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 100 milligram/1 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 2 gram/20 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 2 gram/20 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 500 milligram/5 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 500 milligram/5 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 500 milligram/25 milliliter conventional release solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 500 milligram/25 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cytarabine (substance)	Inferred relationship	Some	1
Product containing only cytarabine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cytarabine (substance)	Inferred relationship	Some	1
Product containing only cytarabine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cytarabine (substance)	Inferred relationship	Some	1
Cytarabine 20 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cytarabine (substance)	Inferred relationship	Some	1
Cytarabine 20 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Cytarabine (substance)	Inferred relationship	Some	1
Cytarabine 100 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Cytarabine (substance)	Inferred relationship	Some	1
Cytarabine 100 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 50 milligram/1 milliliter conventional release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Cytarabine (substance)	Inferred relationship	Some	1
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Cytarabine (substance)	Inferred relationship	Some	1
Product containing only cytarabine and daunorubicin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cytarabine (substance)	Inferred relationship	Some	2
Product containing cytarabine and daunorubicin in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cytarabine (substance)	Inferred relationship	Some	2
Product containing cytarabine and daunorubicin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cytarabine (substance)	Inferred relationship	Some	2
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cytarabine (substance)	Inferred relationship	Some	2
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cytarabine (substance)	Inferred relationship	Some	2
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Cytarabine (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461689012	Cytarabine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481601019	Cytarabine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492134015	Arabinosylcytosine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492135019	Cytosine arabinoside	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492136018	1-beta-D-Arabinofuranosylcytosine	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1492137010	Ara-C	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
4500411000005110	Cytarabin	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)